Mochtar, B.

patient heart cyclosporin transplantation transplant heart transplantation month failure level control recipient heart transplant recipients trough creatinine cyclosporin nephrotoxicity survival function nephrotoxicity treatment trough levels replacement therapy incidence serum study cyclosporine therapy serum creatinine kidney centre cyclosporin trough levels rejection rotterdam group assay disease table number range result difference nephrol cases vs controls dialysis 3 months van gelder 305 heart transplants pre-transplant creatinine clearance cyclosporin dose low-dose cyclosporine therapy cyclosporin doses newton l lung transplant recipients ischaemic heart disease replacement end-stage maintenance treatment nephropathy transplant recipients dose cyclosporin treatment clearance complication effect biopsy polyclonal curve heart recipients insufficiency criteria strategy body weight survival curve endomyocardial biopsy cyclosporine nephrotoxicity gelder cholesterol levels measurement 25121 months case-control study cyclosporin dosage cyclosporine nephropathy